Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma. Academic Article uri icon

Overview

authors

publication date

  • August 23, 2022

Research

keywords

  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Non-Hodgkin

Identity

PubMed Central ID

  • PMC9631665

Scopus Document Identifier

  • 85136465627

Digital Object Identifier (DOI)

  • 10.1016/j.bbmt.2019.08.003

PubMed ID

  • 35687492

Additional Document Info

volume

  • 6

issue

  • 16